151 related articles for article (PubMed ID: 34169610)
21. Anticholinergic medicines in an older primary care population: a cross-sectional analysis of medicines' levels of anticholinergic activity and clinical indications.
Magin PJ; Morgan S; Tapley A; McCowan C; Parkinson L; Henderson KM; Muth C; Hammer MS; Pond D; Mate KE; Spike NA; McArthur LA; van Driel ML
J Clin Pharm Ther; 2016 Oct; 41(5):486-92. PubMed ID: 27349795
[TBL] [Abstract][Full Text] [Related]
22. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
Hsu WH; Wen YW; Chen LK; Hsiao FY
Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
24. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.
Kachru N; Carnahan RM; Johnson ML; Aparasu RR
Drugs Aging; 2015 May; 32(5):379-89. PubMed ID: 25832970
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
26. Anticholinergic Burden in Children, Adults and Older Adults in Slovenia: A Nationwide Database Study.
Cebron Lipovec N; Jazbar J; Kos M
Sci Rep; 2020 Jun; 10(1):9337. PubMed ID: 32518392
[TBL] [Abstract][Full Text] [Related]
27. Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes.
Herrero-Zazo M; Berry R; Bines E; Bhattacharya D; Myint PK; Keevil VL
Ther Adv Drug Saf; 2021; 12():20420986211012592. PubMed ID: 34035892
[TBL] [Abstract][Full Text] [Related]
28. Prevalence, types and associations of medically unexplained symptoms and signs. A cross-sectional study of 1023 adults with intellectual disabilities.
Osugo M; Morrison J; Allan L; Kinnear D; Cooper SA
J Intellect Disabil Res; 2017 Jul; 61(7):637-642. PubMed ID: 28295826
[TBL] [Abstract][Full Text] [Related]
29. How do cognitive and functional impairment relate to the use of anticholinergic medications in hospitalised patients aged 65 years and over?
Kusljic S; Woolley A; Lowe M; Manias E
Aging Clin Exp Res; 2020 Mar; 32(3):423-431. PubMed ID: 31124057
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of mental health conditions, sensory impairments and physical disability in people with co-occurring intellectual disabilities and autism compared with other people: a cross-sectional total population study in Scotland.
Dunn K; Rydzewska E; Fleming M; Cooper SA
BMJ Open; 2020 Apr; 10(4):e035280. PubMed ID: 32341043
[TBL] [Abstract][Full Text] [Related]
31. Adults with intellectual disabilities in China: comorbid psychiatric disorder and its association with health service utilisation.
He P; Chen G; Wang Z; Guo C; Li N; Yun C; Zheng X
J Intellect Disabil Res; 2018 Feb; 62(2):106-114. PubMed ID: 29178565
[TBL] [Abstract][Full Text] [Related]
32. Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study.
Szabo SM; Gooch K; Schermer C; Walker D; Lozano-Ortega G; Rogula B; Deighton A; Vonesh E; Campbell N
BMJ Open; 2019 May; 9(5):e026391. PubMed ID: 31061036
[TBL] [Abstract][Full Text] [Related]
33. Management and prevalence of long-term conditions in primary health care for adults with intellectual disabilities compared with the general population: A population-based cohort study.
Cooper SA; Hughes-McCormack L; Greenlaw N; McConnachie A; Allan L; Baltzer M; McArthur L; Henderson A; Melville C; McSkimming P; Morrison J
J Appl Res Intellect Disabil; 2018 Jan; 31 Suppl 1():68-81. PubMed ID: 28730746
[TBL] [Abstract][Full Text] [Related]
34. Association Between Objectively Measured Physical Activity and Opioid, Hypnotic, or Anticholinergic Medication Use in Older People: Data from the Physical Activity Cohort Scotland Study.
Clarke CL; Sniehotta FF; Vadiveloo T; Donnan PT; Witham MD
Drugs Aging; 2018 Sep; 35(9):835-842. PubMed ID: 30105644
[TBL] [Abstract][Full Text] [Related]
35. The occurrence of comorbidities with affective and anxiety disorders among older people with intellectual disability compared with the general population: a register study.
El Mrayyan N; Eberhard J; Ahlström G
BMC Psychiatry; 2019 Jun; 19(1):166. PubMed ID: 31159756
[TBL] [Abstract][Full Text] [Related]
36. Anticholinergic burden in older women: not seeing the wood for the trees?
Parkinson L; Magin PJ; Thomson A; Byles JE; Caughey GE; Etherton-Beer C; Gnjidic D; Hilmer SN; Lo TK; McCowan C; Moorin R; Pond CD
Med J Aust; 2015 Feb; 202(2):91-4. PubMed ID: 25627741
[TBL] [Abstract][Full Text] [Related]
37. Mental health of older people with mild and moderate intellectual disability in Australia.
Hussain R; Wark S; Janicki MP; Parmenter T; Knox M; Tabatabaei-Jafari H
J Intellect Disabil Res; 2021 Jun; 65(6):535-547. PubMed ID: 33786909
[TBL] [Abstract][Full Text] [Related]
38. Social exclusion and people with intellectual disabilities: a rural-urban comparison.
Nicholson L; Cooper SA
J Intellect Disabil Res; 2013 Apr; 57(4):333-46. PubMed ID: 22458266
[TBL] [Abstract][Full Text] [Related]
39. Anticholinergic and sedative drug burden in community-dwelling older people: a national database study.
Byrne CJ; Walsh C; Cahir C; Ryan C; Williams DJ; Bennett K
BMJ Open; 2018 Jul; 8(7):e022500. PubMed ID: 29982221
[TBL] [Abstract][Full Text] [Related]
40. The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes.
Grill P; Marwick C; De Souza N; Burton JK; Hughes C; Guthrie B
Age Ageing; 2021 Jan; 50(1):183-189. PubMed ID: 32706851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
